Esposito Emanuela, Cuzzocrea Salvatore
IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy.
Br J Pharmacol. 2009 Jun;157(4):494-508. doi: 10.1111/j.1476-5381.2009.00255.x.
A vast amount of circumstantial evidence implicates oxygen-derived free radicals (especially, superoxide and hydroxyl radical) and high-energy oxidants [such as peroxynitrite (OONO(-))] as mediators of shock and ischaemia/reperfusion injury. Reactive oxygen species can initiate a wide range of toxic oxidative reactions. These include initiation of lipid peroxidation, direct inhibition of mitochondrial respiratory chain enzymes, inactivation of glyceraldehyde-3 phosphate dehydrogenase, inhibition of membrane sodium/potassium adenosine 5'-triphosphate-ase activity, inactivation of membrane sodium channels and other oxidative modifications of proteins. All these toxicities are likely to play a role in the pathophysiology of shock and ischaemia and reperfusion. Moreover, various studies have clearly shown that treatment with either OONO(-) decomposition catalysts, which selectively inhibit OONO(-), or with superoxide dismutase (SOD) mimetics, which selectively mimic the catalytic activity of the human SOD enzymes, have been shown to prevent in vivo the delayed vascular decompensation and the cellular energetic failure associated with shock and ischaemia/reperfusion injury.
大量的间接证据表明,氧衍生的自由基(尤其是超氧阴离子和羟基自由基)以及高能氧化剂[如过氧亚硝酸盐(OONO(-))]是休克和缺血/再灌注损伤的介质。活性氧可以引发一系列有毒的氧化反应。这些反应包括引发脂质过氧化、直接抑制线粒体呼吸链酶、使甘油醛-3-磷酸脱氢酶失活、抑制膜钠/钾腺苷三磷酸酶活性、使膜钠通道失活以及蛋白质的其他氧化修饰。所有这些毒性作用可能在休克、缺血和再灌注的病理生理学中发挥作用。此外,各种研究清楚地表明,用选择性抑制OONO(-)的OONO(-)分解催化剂或选择性模拟人类超氧化物歧化酶(SOD)催化活性的SOD模拟物进行治疗,已被证明可在体内预防与休克和缺血/再灌注损伤相关的延迟性血管失代偿和细胞能量衰竭。